ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in ESSA Pharma Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −9 vs. Q4 2024
- Shares held
- 31.7M
- −1.15M (−3.5%) vs. Q4 2024
- Total value
- $50.1M
- −$8.71M (−14.8%) vs. Q4 2024
- New holders
- 3
- 7 more added
- Sold out
- 12
- 10 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 355 | $561 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $948 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 817 | $1.00K | 0.00% | −101−11.0% | Reduced |
| TD Waterhouse Canada Inc. | 900 | $1.40K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 2,500 | $3.67K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 3,688 | $5.83K | 0.00% | −253−6.4% | Reduced |
| Federation des caisses Desjardins du Quebec | 4,050 | $6.40K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,000 | $9.48K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,074 | $11.2K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 14,115 | $22.3K | 0.00% | −12,172−46.3% | Reduced |
| Group One Trading, L.P. | 21,118 | $33.4K | 0.00% | −15,230−41.9% | Reduced |
| XTX Topco Ltd | 22,829 | $36.1K | 0.00% | −14,697−39.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 22,843 | $36.1K | 0.00% | −26,000−53.2% | Reduced |
| UBS Group AG | 23,608 | $37.3K | 0.00% | −72,006−75.3% | Reduced |
| Shay Capital LLC | 24,631 | $38.9K | 0.01% | +24,631 | New |
| Geode Capital Management, LLC | 26,858 | $42.4K | 0.00% | 00.0% | Unchanged |
| Lepercq De Neuflize Asset Management LLC | 31,700 | $50.1K | 0.05% | +1,500+5.0% | Added |
| American Century Companies Inc | 46,373 | $73.3K | 0.00% | 00.0% | Unchanged |
| Magnus Financial Group LLC | 55,206 | $87.2K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 82,123 | $129.8K | 0.00% | −76,918−48.4% | Reduced |
| Deuterium Capital Management, LLC | 110,412 | $174.5K | 0.39% | +110,412 | New |
| JPMorgan Chase & Co | 164,875 | $260.5K | 0.00% | +164,854+785,019.0% | Added |
| DLD Asset Management, LP | 183,658 | $290.2K | 0.04% | +183,658 | New |
| BNP Paribas Arbitrage, SA | 235,401 | $371.9K | 0.00% | +70,806+43.0% | Added |
| Two Sigma Advisers, LP | 276,100 | $436.2K | 0.00% | +193,500+234.3% | Added |
| Two Sigma Investments, LP | 279,120 | $441.0K | 0.00% | +67,916+32.2% | Added |
| Aldebaran Capital, LLC | 569,294 | $899.5K | 0.85% | +171,771+43.2% | Added |
| Bank of America Corp | 698,268 | $1.10M | 0.00% | −114,042−14.0% | Reduced |
| Altium Capital Management LP | 1,050,369 | $1.66M | 4.82% | −377,631−26.4% | Reduced |
| Pfizer Inc | 1,675,000 | $2.65M | 0.53% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,209,998 | $3.49M | 0.78% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,262,026 | $3.57M | 0.28% | 00.0% | Unchanged |
| BML Capital Management, LLC | 4,221,546 | $6.67M | 5.40% | 00.0% | Unchanged |
| Morgan Stanley | 4,299,768 | $6.79M | 0.00% | +103,899+2.5% | Added |
| Tang Capital Management LLC | 4,300,000 | $6.79M | 0.38% | 00.0% | Unchanged |
| BVF Inc | 8,748,629 | $13.8M | 0.56% | 00.0% | Unchanged |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,113,002−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −181,217−100.0% | Sold out |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −45,810−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,704−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,943−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −15,687−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,525−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −11,172−100.0% | Sold out |